Hsp90 as a therapeutic target in endocrinology: current evidence

Thomas Ratajczak1 Laboratory for Molecular Endocrinology, Harry Perkins Institute of Medical Research and The UWA Centre for Medical Research, The University of Western Australia;2 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital AvenueCorrespondence[email protected]

Bryan Kenneth Ward1 Laboratory for Molecular Endocrinology, Harry Perkins Institute of Medical Research and The UWA Centre for Medical Research, The University of Western Australia;2 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue

John Peter Walsh2 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue;3 School of Medicine and Pharmacology, The University of Western Australia, Nedlands, WA, Australia

Carmel Cluning1 Laboratory for Molecular Endocrinology, Harry Perkins Institute of Medical Research and The UWA Centre for Medical Research, The University of Western Australia;2 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue

Hsp90 as a therapeutic target in endocrinology: current evidence

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hsp90 as a therapeutic target in endocrinology: current evidence

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date